Plasma proteins modified by tyrosine nitration in acute respiratory distress syndrome

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 278, Issue 5 22-5, 2000, Pages

  Gole, Madhura D ^a   Souza, Jose M ^a   Choi, Irene ^a   Hertkorn, Caryn ^a   Malcolm, Stuart ^a   Foust III, Raymond F ^a   Finkel, Barbara ^b   Lanken, Paul N ^b   Ischiropoulos, Harry ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Ceruloplasmin; Fibrinogen; Nitric oxide; Oxidative stress; Superoxide; 1 protease inhibitor

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; CERULOPLASMIN; FIBRINOGEN; NITRIC OXIDE; PLASMA PROTEIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; IMMUNOPRECIPITATION; NITRATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY DISTRESS;

EID: 0034073045     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2000.278.5.l961     Document Type: Article

References (47)

1. Alvarez B, Ferrer-Sueta G, Freeman BA, and Radi R. Kinetics of peroxynitrite reaction with amino acids and human serum albumin. J Biol Chem 274: 842-848, 1998.
2. Ara J, Przedborski S, Naini AB, Jackson-Lewis V, Trifiletti RR, Horwitz J, and Ischiropoulos H. Inactivation of tyrosine hydroxylase following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 95: 7659-7663, 1998.
3. Ayata C, Ayata G, Kara H, Matthews RT, Beal MF, Ferrante RJ, Endres M, Kim A, Christie RH, Waeber C, Huang PL, Hyman BT, and Moskowitz MA. Mechanisms of reduced striatal NMDA excitotoxicity in type 1 nitric oxide synthase knock-out mice. J Neurosci 17: 6908-6917, 1997.
4. Bacofen ME and Weibel R. Structural alterations of the lung parenchyma in the adult respiratory distress syndrome. Clin Chest Med 3: 35-56, 1982.
5. Balwin SR, Grum CM, Boxer LA, Simon RH, Ketal LH, and Devall LJ. Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet 1: 11-14, 1986.
6. Banks BA, Ischiropoulos H, McClelland M, Ballard PL, and Ballard RA. Plasma 3-nitrotyrosine is elevated in premature infants who develop bronchopulmonary dysplasia. Pediatrics 101: 870-874, 1998.
7. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, and Spragg R. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149: 818-824, 1994.
8. Brett SJ and Evans TW. Measurement of endogenous nitric oxide in the lungs of patients with adult respiratory distress syndrome. Am J Respir Crit Care Med 157: 993-997, 1998.
9. Burthis CA and Ashwood ER (Editors). Tietz Textbook of Clinical Chemistry. Philadelphia, PA: Saunders, 1994, p. 671-675.
10. Donnelly SC, McGregor I, Zamani A, Gordon MWG, Robertson CE, Steedman DJ, Little K, and Haslett C. Plasma elastase levels and the development of the adult respiratory distress syndrome. Am J Respir Crit Care Med 151: 1428-1433, 1995.
11. Estevez AG, Spear N, Manuel SM, Radi R, Henderson CE, Barbeito L, and Beckman JS. Nitric oxide and superoxide contribute to motor neuron apoptosis induced by trophic factor deprivation. J Neurosci 18: 923-931, 1998.
12. Ferrante RJ, Hantraye P, Brouillet E, and Beal MF. Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP-treated baboons is blocked by inhibition of neuronal nitric oxide synthase. Brain Res 823: 177-182, 1999.
13. 1-proteinase inhibitor upon chemical modification of its tyrosyl residues. J Biol Chem 256: 6374-6380, 1981.
14. Freeman BA and Crapo JD. Biology of the disease: free radicals and tissue injury. Lab Invest 47: 412-426, 1982.
15. Gladstone IM Jr and Levine RM. Oxidation of proteins in neonatal lungs. Pediatrics 93: 764-768, 1994.
16. Gow A, Duran D, Thom SR, and Ischiropoulos H. Carbon dioxide enhancement of peroxynitrite-mediated protein tyrosine nitration. Arch Biochem Biophys 333: 42-48, 1997.
17. Gutteridge JM, Quinlan GJ, Mumby S, Heath A, and Evans TW. Primary plasma antioxidants in the adult respiratory distress syndrome patients: changes in iron-oxidizing, iron-binding, free radical-scavenging proteins. J Lab Clin Med 124: 263-273, 1994.
18. Haddad IY, Pataki G, Hu P, Galliani C, Beckman JS, and Matalon S. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J Clin Invest 94: 2407-2413, 1994.
19. Idell S, Koening KB, Fair DS, Martin TR, McLatry J, and Maudner RJ. Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 261: L240-L248, 1991.
20. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 356: 1-11, 1998.
21. Kollef MH and Schuster DP. The acute respiratory distress syndrome. N Engl J Med 332: 27-37, 1997.
22. Krsek-Staples JA, Kew RR, and Webster RO. Ceruloplasmin and transferrin levels are altered in serum and bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Am Rev Respir Dis 145: 1009-1015, 1991.
23. Lamb NJ, Gutteridge JMC, Baker C, Evans TW, and Quinlan GJ. Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with ARDS: evidence for neutrophil mediated hydroxylation, nitration and chlorination. Crit Care Med 27: 1738-1744, 1999.
24. Lamb NJ, Gutteridge JMC, Baker C, Evans TW, and Quinlan GJ. Nitration of proteins in bronchoalveolar lavage fluid from patients with acute respiratory distress syndrome receiving inhaled nitric oxide. Am J Respir Crit Care Med 160: 1031-1034, 1999.
25. Lee CT, Fein AM, Lipmann M, Holtzmann H, Kimbel P, and Weinbaum G. Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory distress syndrome. N Engl J Med 304: 192-196, 1981.
26. Line WF, Grohlich D, and Bezkorovainy A. The effect of chemical modification on the iron binding properties of human transferrin. Biochemistry 6: 3393-3402, 1967.
27. Louie S, Halliwell B, and Cross CE. Adult respiratory distress syndrome: a radical perspective. Adv Pharmacol 38: 457-490, 1997.
28. Lykens MG, Davis WB, and Pacht ER. Antioxidant activity of bronchoalveolar lavage fluid in the adult respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 262: L169-L175, 1992.
29. MacMillan-Crow LA, Crow JP, Kerby JD, Beckman JS, and Thompson JA. Nitration and inactivation of Mn superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci USA 93: 11853-11858, 1996.
30. Marthru M, Rooney MW, Dries DJ, Hirsch LJ, Barnes L, and Tobin MH. Urine hydrogen peroxide during ARDS in patients with and without sepsis. Chest 105: 232-236, 1994.
31. Mierzwa S and Chan SK. Chemical modification of human a1-proteinase inhibitor by tetranitromethane. Biochem J 246: 37-42, 1987.
32. Moreno JJ and Pryor WA. Inactivation of α-1-proteinase inhibitor by peroxynitrite. Chem Res Toxicol 5: 425-431, 1992.
33. Ohshima H, Celan I, Chazotte L, Pignatelli B, and Mower HF. Analysis of 3-nitrotyrosine in biological fluids and protein hydrolyzates by HPLC using a postseparation, on-line reduction column and electrochemical detection: results with various nitrating agents. Nitric Oxide 3: 132-141, 1999.
34. Pennathur S, Jackson-Lewis V, Przedborski S, and Heinecke JW. Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o-o′-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease. J Biol Chem 274: 34621-34628, 1999.
35. Pittet JF, Mackersie RC, Martin TR, and Matthay MA. Biological markers of acute lung injury: prognosis and pathogenic significance. Am J Respir Crit Care Med 155: 1187-1205, 1997.
36. Repine JE. Scientific perspectives on adult respiratory distress syndrome. Lancet 339: 466-469, 1992.
37. Roumen RM, Hendriks T, Man BMD, and Goris RJ. Serum lipofuscin as a prognostic indicator of ARDS and multiple organ failure. Br J Surg 81: 1300-1305, 1994.
38. Quinlan GJ, Lamb NJ, Evans TW, and Gutteridge JMC. Plasma fatty acid changes and increased lipid peroxidation in patients with ARDS. Crit Care Med 24: 241-246, 1996.
39. Quinn DA, Carvalho AC, Geller E, Khaw BA, Barlaikovach M, Zielonka J, Greene R, Strauss HW, and Zapol WM. 99m Tc-fibrinogen scanning in the adult respiratory distress syndrome. Am Rev Respir Dis 135: 930-936, 1987.
40. Shacter E, Williams JA, Lim M, and Levine RL. Differential susceptibility of plasma proteins to oxidative modification: examination by Western blot analysis. Free Radic Biol Med 17: 429-437, 1994.
41. Shacter E, Williams JA, Lim M, and Levine RL. Oxidative modification of fibrinogen inhibits thrombin-catalyzed clot formation. Free Radic Biol Med 18: 815-821, 1995.
42. Souza JM, Daikhin E, Yudkoff M, and Ischiropoulos H. Factors determining the selectivity of protein tyrosine nitration. Arch Biochem Biophys 371: 169-178, 1999.
43. Stadtman ER. Protein oxidation and aging. Science 257: 1220-1224, 1992.
44. Suter PM, Sute S, Girardin E, Roux-Lombard P, Grau GE, and Dayer JM. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, elastase, in patients with adult respiratory distress syndrome after trauma, shock or sepsis. Am Rev Respir Dis 145: 1016-1022, 1992.
45. Van der Vliet A, Eiserich JP, Halliwell B, and Cross CE. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. J Biol Chem 272: 7617-7625, 1997.
46. Wu W, Chen Y, and Hazen SL. Eosinophil peroxidase nitrates protein tyrosyl residues. J Biol Chem 274: 25933-25944, 1999.
47. Zhu S, Geiser T, Ware LB, Matthay MA, and Matalon S. Nitrate levels are elevated in the pulmonary edema fluid and plasma of patients with acute lung injury (Abstract). Am J Respir Crit Care Med 159: A592, 1999.